Back
Insmed Vs. Fulcrum Therapeutics Industry Stock Comparison
Buy
57
INSM
Insmed
Last Price:
74.29
Seasonality Move:
0.25%
Sell
2
FULC
Fulcrum Therapeutics
Last Price:
3.36
Seasonality Move:
3.98%
Buy
57
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $74.21. The Score for INSM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
2
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.35. The Score for FULC is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight selling pressure.
INSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 50.96 | Buy |
Chaikin Money Flow: | -2039265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.73 - 77.05) | Sell |
Bollinger Bands (100): | (42.96 - 80.58) | Buy |
FULC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.46 | Sell |
Relative Strength Index (14 RSI): | 23.99 | Sell |
Chaikin Money Flow: | -371836 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.83 - 9.83) | Sell |
Bollinger Bands (100): | (6.16 - 9.16) | Sell |
INSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 73.74 | Buy |
20-day SMA: | 74.31 | Sell |
50-day SMA: | 74.69 | Sell |
200-day SMA: | 44.8 | Buy |
8-day EMA: | 73.81 | Buy |
20-day EMA: | 74 | Buy |
50-day EMA: | 71.64 | Buy |
200-day EMA: | 51.09 | Buy |
FULC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.05 | Sell |
20-day SMA: | 6.84 | Sell |
50-day SMA: | 8.03 | Sell |
200-day SMA: | 7.87 | Sell |
8-day EMA: | 4.29 | Sell |
20-day EMA: | 6.03 | Sell |
50-day EMA: | 7.26 | Sell |
200-day EMA: | 7.41 | Sell |
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.10 per share, and an increase next year of $1.11 per share.
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.15 per share, an increase this year of $1.40 per share, and a decrease next year of $0.79 per share.
Insmed Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fulcrum Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |